107 related articles for article (PubMed ID: 18070983)
1. NF-kappaB-dependent control of HIV-1 transcription by the second coding exon of Tat in T cells.
Mahlknecht U; Dichamp I; Varin A; Van Lint C; Herbein G
J Leukoc Biol; 2008 Mar; 83(3):718-27. PubMed ID: 18070983
[TBL] [Abstract][Full Text] [Related]
2. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
Chang LJ; Zhang C
Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator.
Roof P; Ricci M; Genin P; Montano MA; Essex M; Wainberg MA; Gatignol A; Hiscott J
Virology; 2002 Apr; 296(1):77-83. PubMed ID: 12036319
[TBL] [Abstract][Full Text] [Related]
5. The lipophosphoglycan of Leishmania donovani up-regulates HIV-1 transcription in T cells through the nuclear factor-kappaB elements.
Bernier R; Barbeau B; Tremblay MJ; Olivier M
J Immunol; 1998 Mar; 160(6):2881-8. PubMed ID: 9510191
[TBL] [Abstract][Full Text] [Related]
6. H. saimiri tyrosine-kinase interacting protein inhibits Tat function: a prototypic strategy for restricting HIV-1-induced cytopathic effects in immune cells.
Raymond AD; Hasham M; Tsygankov AY; Henderson EE
Virology; 2006 Sep; 352(2):253-67. PubMed ID: 16780912
[TBL] [Abstract][Full Text] [Related]
7. Influenza virus activates human immunodeficiency virus type-1 gene expression in human CD4-expressing T cells through an NF-kappaB-dependent pathway.
Sun J; Bergeron M; Barbeau B; Boivin G; Tremblay MJ
Clin Immunol; 2005 Feb; 114(2):190-8. PubMed ID: 15639653
[TBL] [Abstract][Full Text] [Related]
8. TAT-mediated transcellular activation of HIV-1 long terminal repeat directed gene expression by HIV-1-infected peripheral blood mononuclear cells.
Thomas CA; Dobkin J; Weinberger OK
J Immunol; 1994 Oct; 153(8):3831-9. PubMed ID: 7930599
[TBL] [Abstract][Full Text] [Related]
9. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
[TBL] [Abstract][Full Text] [Related]
10. On the role of the second coding exon of the HIV-1 Tat protein in virus replication and MHC class I downregulation.
Verhoef K; Bauer M; Meyerhans A; Berkhout B
AIDS Res Hum Retroviruses; 1998 Nov; 14(17):1553-9. PubMed ID: 9840288
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of TAT-induced transactivation of the HIV-1 LTR by two genomic fragments of HHV-6.
Garzino-Demo A; Chen M; Lusso P; Berneman Z; DiPaolo JA
J Med Virol; 1996 Sep; 50(1):20-4. PubMed ID: 8890036
[TBL] [Abstract][Full Text] [Related]
12. Derivation of infectious HIV-1 molecular clones with LTR mutations: sensitivity to the CD8+ cell noncytotoxic anti-HIV response.
Bonneau KR; Ng S; Foster H; Choi KB; Berkhout B; Rabson A; Mackewicz CE; Levy JA
Virology; 2008 Mar; 373(1):30-8. PubMed ID: 18086484
[TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen species activate HIV long terminal repeat via post-translational control of NF-kappaB.
Pyo CW; Yang YL; Yoo NK; Choi SY
Biochem Biophys Res Commun; 2008 Nov; 376(1):180-5. PubMed ID: 18765232
[TBL] [Abstract][Full Text] [Related]
14. 4-Phenylcoumarins as HIV transcription inhibitors.
Bedoya LM; Beltrán M; Sancho R; Olmedo DA; Sánchez-Palomino S; del Olmo E; López-Pérez JL; Muñoz E; San Feliciano A; Alcamí J
Bioorg Med Chem Lett; 2005 Oct; 15(20):4447-50. PubMed ID: 16137881
[TBL] [Abstract][Full Text] [Related]
15. [The mechanism of HIV replication at the site of inflammation coinfected with HIV and M. tuberculosis].
Nakata K; Keicho N; Honda Y; Nagai H; Hebisawa A; Fujita A
Kekkaku; 2002 Oct; 77(10):687-92. PubMed ID: 12440144
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region.
Caputo A; Grossi MP; Bozzini R; Rossi C; Betti M; Marconi PC; Barbanti-Brodano G; Balboni PG
Gene Ther; 1996 Mar; 3(3):235-45. PubMed ID: 8646555
[TBL] [Abstract][Full Text] [Related]
17. Mesuol, a natural occurring 4-phenylcoumarin, inhibits HIV-1 replication by targeting the NF-kappaB pathway.
Márquez N; Sancho R; Bedoya LM; Alcamí J; López-Pérez JL; Feliciano AS; Fiebich BL; Muñoz E
Antiviral Res; 2005 Jun; 66(2-3):137-45. PubMed ID: 15911030
[TBL] [Abstract][Full Text] [Related]
18. Recent status of HIV-1 gene expression inhibitors.
Baba M
Antiviral Res; 2006 Sep; 71(2-3):301-6. PubMed ID: 16488488
[TBL] [Abstract][Full Text] [Related]
19. PGJ2 antagonizes NF-kappaB-induced HIV-1 LTR activation in colonic epithelial cells.
Boisvert M; Côté S; Vargas A; Pasvanis S; Bounou S; Barbeau B; Dumais N
Virology; 2008 Oct; 380(1):1-11. PubMed ID: 18755491
[TBL] [Abstract][Full Text] [Related]
20. Denbinobin, a naturally occurring 1,4-phenanthrenequinone, inhibits HIV-1 replication through an NF-kappaB-dependent pathway.
Sánchez-Duffhues G; Calzado MA; de Vinuesa AG; Caballero FJ; Ech-Chahad A; Appendino G; Krohn K; Fiebich BL; Muñoz E
Biochem Pharmacol; 2008 Nov; 76(10):1240-50. PubMed ID: 18840408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
